Evolus, Inc. (EOLS) stock

EOLSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30

$6.96−0.22 (-3.06%)

Close on Nov 13, 2026Market cap $459.71MP/E –Yield –

Evolus statistics

83 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 2, 2027 (estimated, during market hours)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $459.71M; $272.32M
Enterprise Value: $574.91M; $146.23M
PS Ratio: 1.41; 3.66

Enterprise valuationIndustry

EV / Sales: 1.77; 2.57

Share statisticsIndustry

Shares Outstanding: 66M; 58M
Shares Change (YoY): 2.25%; 10.8%
Shares Change (QoQ): 0.19%; 0.50%
Float: 63M; 49M
Shares Held by Insiders: 4.07%; 11.7%
Shares Held by Institutions: 84.0%; 56.4%

Short sellingIndustry

Short Interest: 6M; –
Short Interest Change: -6.02%; -0.80%
Short % of Float: 9.51%; 9.01%
Short % of Shares Outstanding: 9.12%; 6.30%
Days to Cover: 9.38; 5.15

Stock price statisticsIndustry

52-Week High: $9.31; –
52-Week Low: $3.86; –
20-Day Moving Average: $7.23; –
50-Day Moving Average: $7.62; –
200-Day Moving Average: $6.37; –
Average True Range (14): $0.40; –
Price Change (1 Week): 2.28%; -1.15%
Price Change (1 Month): -8.06%; -4.87%
Price Change (3 Months): -10.4%; -21.0%
Price Change (6 Months): 7.08%; -20.6%
Price Change (YTD): 4.66%; -23.6%
Price Change (1 Year): -4.66%; -22.4%
Price Change (3 Years): -17.6%; -29.5%
Price Change (5 Years): -3.60%; -77.9%
Average Volume (10 Days): 2M; –
Average Volume (20 Days): 1M; –
Average Volume (90 Days): 932,257; –
Relative Volume: 0.49; 0.70
Relative Strength Index (14): 44.3; 43.4
Volatility (1 Year): 67.2%; 80.1%
Beta (5 Years): 1.13; 1.07

MarginsIndustry

Gross Margin: 66.4%; 53.1%
Operating Margin: -4.79%; -38.7%
Pretax Margin: -9.32%; -11.6%
Profit Margin: -9.56%; -31.6%
EBITDA Margin: -2.43%; -27.7%
FCF Margin: -1.51%; -9.56%

Returns on capitalIndustry

Return on Assets (ROA): -12.4%; -40.6%
Return on Invested Capital (ROIC): -16.3%; -32.9%
Return on Capital Employed (ROCE): -11.0%; -37.9%

Financial positionIndustry

Current Ratio: 1.42; 3.30
Quick Ratio: 0.72; 2.39
Interest Coverage: -0.95; -6.35

GrowthIndustry

Revenue Growth (YoY): 13.9%; 6.82%
Revenue Growth (3Y CAGR): 26.0%; 2.25%
Revenue Growth (5Y CAGR): 39.4%; 6.41%

EfficiencyIndustry

Asset Turnover: 1.29; 0.40
Inventory Turnover: 1.89; 2.73
Revenue Per Employee: $974.47K; $429.29K
Profits Per Employee: -$93.15K; -$689.41K
Employee Count: 334; 74
WACC: 10.1%; 10.2%

Income statement (TTM)Industry

Revenue: $325.47M; $66.37M
Gross Profit: $216.05M; $120.78M
Operating Income: -$15.60M; -$21.37M
Pretax Income: -$30.34M; -$12.95M
Net Income: -$31.11M; -$22.35M
EBITDA: -$7.89M; -$17.21M
EPS (Diluted): -$0.47; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $41.70M; $68.68M
Total Debt: $156.90M; $116.91M
Net Cash (Debt): -$115.20M; $17.76M
Net Cash Per Share: -$1.74; $0.80
Equity (Book Value): -$37.81M; $53.89M
Book Value Per Share: -$0.57; $1.50
Tangible Book Value: -$105.75M; $27.13M
Working Capital: $59.36M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$2.65M; -$12.38M
Capital Expenditures: -$2.26M; -$1.00M
Free Cash Flow: -$4.91M; -$18.21M
FCF Per Share: -$0.07; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -6.77%; -21.8%
FCF Yield: -1.07%; -9.44%

Taxes and interestIndustry

Interest Expense: $16.37M; $2.90M
Income Tax: $772.00K; $73.00K

Scores and fair valueIndustry

Altman Z-Score: -1.34; 0.23
Piotroski F-Score: 2; 4
Beneish M-Score: -2.59; -2.63

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	EOLS	S&P 500	Difference	EOLS per year	S&P 500 per year
1 month	-7.3%	-3.0%	−4.3 pts
3 months	-13.2%	-2.8%	−10.4 pts
Year to date	+4.7%	+11.5%	−6.8 pts
1 year	-5.6%	+13.5%	−19.0 pts
3 years	-14.3%	+77.7%	−92.0 pts	-5.0%	+21.1%
5 years	-3.6%	+72.6%	−76.2 pts	-0.7%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

6M EOLS shares were sold short on Oct 30, 2026, down 6.0% from the previous report, or 9.51% of the shares available to trade. At recent volumes it would take 9.4 days to buy them back. Over the last 20 sessions, 57.6% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	6,023,009	-6.0%	642,143	9.4
Oct 15, 2026	6,408,688	+13.9%	906,582	7.1
Sep 30, 2026	5,628,168	+1.8%	603,494	9.3
Sep 15, 2026	5,530,759	+3.0%	837,573	6.6
Aug 31, 2026	5,368,957	-8.3%	1,029,865	5.2
Aug 14, 2026	5,853,655	+5.1%	1,338,914	4.4
Jul 31, 2026	5,568,442	-5.7%	637,372	8.7
Jul 15, 2026	5,905,990	-1.9%	805,874	7.3
Jun 30, 2026	6,018,141	+2.1%	824,575	7.3
Jun 15, 2026	5,895,218	-2.7%	733,042	8.0
May 29, 2026	6,059,626	-1.8%	741,098	8.2
May 15, 2026	6,173,524	-7.3%	1,158,260	5.3